vs
Side-by-side financial comparison of Graham Holdings Co (GHC) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.2× Graham Holdings Co). Graham Holdings Co runs the higher net margin — 8.7% vs -13.6%, a 22.3% gap on every dollar of revenue. On growth, Graham Holdings Co posted the faster year-over-year revenue change (0.4% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $5.0M). Over the past eight quarters, Graham Holdings Co's revenue compounded faster (4.2% CAGR vs -3.6%).
Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
GHC vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.5B |
| Net Profit | $108.7M | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | 3.8% | -9.8% |
| Net Margin | 8.7% | -13.6% |
| Revenue YoY | 0.4% | -5.3% |
| Net Profit YoY | -80.2% | -288.1% |
| EPS (diluted) | $24.76 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.3B | $1.6B | ||
| Q2 25 | $1.2B | $1.6B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $1.2B | $1.6B | ||
| Q1 24 | $1.2B | $1.6B |
| Q4 25 | $108.7M | $-205.0M | ||
| Q3 25 | $122.9M | $160.0M | ||
| Q2 25 | $36.7M | $145.0M | ||
| Q1 25 | $23.9M | $87.0M | ||
| Q4 24 | $548.8M | $109.0M | ||
| Q3 24 | $72.5M | $359.0M | ||
| Q2 24 | $-21.0M | $195.0M | ||
| Q1 24 | $124.4M | $201.0M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% | ||
| Q1 24 | — | 59.0% |
| Q4 25 | 3.8% | -9.8% | ||
| Q3 25 | 5.2% | 15.2% | ||
| Q2 25 | 6.0% | 14.4% | ||
| Q1 25 | 4.1% | 6.7% | ||
| Q4 24 | 5.8% | 8.1% | ||
| Q3 24 | 6.8% | 13.1% | ||
| Q2 24 | 2.2% | 14.6% | ||
| Q1 24 | 3.1% | 14.5% |
| Q4 25 | 8.7% | -13.6% | ||
| Q3 25 | 9.6% | 10.0% | ||
| Q2 25 | 3.0% | 9.1% | ||
| Q1 25 | 2.0% | 5.8% | ||
| Q4 24 | 44.1% | 6.8% | ||
| Q3 24 | 6.0% | 22.7% | ||
| Q2 24 | -1.8% | 12.1% | ||
| Q1 24 | 10.8% | 12.4% |
| Q4 25 | $24.76 | $-0.78 | ||
| Q3 25 | $27.91 | $0.61 | ||
| Q2 25 | $8.35 | $0.56 | ||
| Q1 25 | $5.45 | $0.33 | ||
| Q4 24 | $124.05 | $0.42 | ||
| Q3 24 | $16.42 | $1.38 | ||
| Q2 24 | $-4.79 | $0.75 | ||
| Q1 24 | $27.72 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $267.0M | $574.0M |
| Total DebtLower is stronger | — | $8.6B |
| Stockholders' EquityBook value | $4.8B | $752.0M |
| Total Assets | $8.4B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $267.0M | $574.0M | ||
| Q3 25 | $190.8M | $672.0M | ||
| Q2 25 | $176.2M | $599.0M | ||
| Q1 25 | $156.7M | $547.0M | ||
| Q4 24 | $260.9M | $675.0M | ||
| Q3 24 | $244.4M | $763.0M | ||
| Q2 24 | $140.7M | $704.0M | ||
| Q1 24 | $130.9M | $575.0M |
| Q4 25 | — | $8.6B | ||
| Q3 25 | — | $8.8B | ||
| Q2 25 | — | $8.9B | ||
| Q1 25 | — | $9.0B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $4.8B | $752.0M | ||
| Q3 25 | $4.5B | $906.0M | ||
| Q2 25 | $4.4B | $733.0M | ||
| Q1 25 | $4.3B | $542.0M | ||
| Q4 24 | $4.3B | $472.0M | ||
| Q3 24 | $4.0B | $493.0M | ||
| Q2 24 | $4.0B | $144.0M | ||
| Q1 24 | $4.0B | $48.0M |
| Q4 25 | $8.4B | $12.9B | ||
| Q3 25 | $7.9B | $13.6B | ||
| Q2 25 | $7.6B | $13.5B | ||
| Q1 25 | $7.6B | $13.2B | ||
| Q4 24 | $7.7B | $13.1B | ||
| Q3 24 | $7.4B | $12.8B | ||
| Q2 24 | $7.2B | $12.2B | ||
| Q1 24 | $7.3B | $11.9B |
| Q4 25 | — | 11.49× | ||
| Q3 25 | — | 9.74× | ||
| Q2 25 | — | 12.14× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | — | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.3M | $141.0M |
| Free Cash FlowOCF − Capex | $5.0M | $96.0M |
| FCF MarginFCF / Revenue | 0.4% | 6.4% |
| Capex IntensityCapex / Revenue | 1.9% | 3.0% |
| Cash ConversionOCF / Net Profit | 0.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | $275.3M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.3M | $141.0M | ||
| Q3 25 | $178.1M | $264.0M | ||
| Q2 25 | $94.8M | $220.0M | ||
| Q1 25 | $46.0M | $75.0M | ||
| Q4 24 | $116.3M | $390.0M | ||
| Q3 24 | $237.6M | $141.0M | ||
| Q2 24 | $52.0M | $332.0M | ||
| Q1 24 | $1.1M | $76.0M |
| Q4 25 | $5.0M | $96.0M | ||
| Q3 25 | $161.8M | $218.0M | ||
| Q2 25 | $78.0M | $181.0M | ||
| Q1 25 | $30.5M | $43.0M | ||
| Q4 24 | $91.1M | $335.0M | ||
| Q3 24 | $219.4M | $99.0M | ||
| Q2 24 | $33.7M | $300.0M | ||
| Q1 24 | $-20.2M | $30.0M |
| Q4 25 | 0.4% | 6.4% | ||
| Q3 25 | 12.6% | 13.6% | ||
| Q2 25 | 6.4% | 11.4% | ||
| Q1 25 | 2.6% | 2.8% | ||
| Q4 24 | 7.3% | 21.0% | ||
| Q3 24 | 18.2% | 6.3% | ||
| Q2 24 | 2.8% | 18.7% | ||
| Q1 24 | -1.8% | 1.8% |
| Q4 25 | 1.9% | 3.0% | ||
| Q3 25 | 1.3% | 2.9% | ||
| Q2 25 | 1.4% | 2.4% | ||
| Q1 25 | 1.3% | 2.1% | ||
| Q4 24 | 2.0% | 3.5% | ||
| Q3 24 | 1.5% | 2.7% | ||
| Q2 24 | 1.5% | 2.0% | ||
| Q1 24 | 1.8% | 2.8% |
| Q4 25 | 0.26× | — | ||
| Q3 25 | 1.45× | 1.65× | ||
| Q2 25 | 2.58× | 1.52× | ||
| Q1 25 | 1.93× | 0.86× | ||
| Q4 24 | 0.21× | 3.58× | ||
| Q3 24 | 3.28× | 0.39× | ||
| Q2 24 | — | 1.70× | ||
| Q1 24 | 0.01× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GHC
| Products | $602.7M | 48% |
| Kaplan International | $251.9M | 20% |
| Manufacturing | $117.8M | 9% |
| Television Broadcasting | $110.5M | 9% |
| Higher Education | $83.8M | 7% |
| Supplemental Education | $74.9M | 6% |
| Related Party | $4.4M | 0% |
OGN
Segment breakdown not available.
